UBX

Unity Biotechnology (UBX)

About Unity Biotechnology (UBX)

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.

Details

Daily high

$1.80

Daily low

$1.70

Price at open

$1.75

52 Week High

$3.10

52 Week Low

$0.94

Market cap

30.2M

Dividend yield

0.00%

Volume

33,064

Avg. volume

110,861

P/E ratio

-1.16

Unity Biotechnology News